Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04317729Not ApplicableCompleted
DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV
Hepatitis C Virus Infection
PrincipalinvestigatorStart date: 2020-01-30

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Medical Centre Astar

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maria Prins, Prof. dr.

Public Health Service of Amsterdam (GGD Amsterdam)

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Camilo Zaks, MD

University of Southern California, Keck School of Medicine of USC, Department of Family Medicine, USC Street Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Chia-Yen Dai, M.D., M.S.

Kaohsiung Municipal United Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Darlene Bhavnani, PhD MPH

The University of Texas at Austin Dell Medical School

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Javier Hernández Blanco, MD

Asociación Colombiana de Hepatología

Moderately Similar
2 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

George Wu, MD

University of Connecticut

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Ming-Lung Yu, M.D., Ph.D.

Kaohsiung Municipal United Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Pablo Tebas, M.D.

University of Pennsylvania

Moderately Similar
3 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Xuegang Wu

Ginkgo Pharma Co., Ltd.

Moderately Similar
2 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Alberto Sanchez-Fueyo, MD

Hospital Clinic Barcelona / IDIBAPS, Barcelona, Spain

Moderately Similar
2 trials

Shared therapeutic areas:

Hepatitis C Virus Infection
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04317729Not ApplicablePrincipalInvestigator

DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

Hepatitis C Virus Infection
Completed

All 1 trials loaded